Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05320887 · ClinicalTrials.gov registry record · NA
Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM)
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT05320887 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 69 participants.
The verdict
NCT05320887, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
This study is proposing a four condition Electronic Tobacco Marketplace (ETM) study to determine if banning normal nicotine content (NNC) is sufficient for encouraging smokers to switch to potentially less harmful products or if the availability of higher nicotine and/or flavored alternative products (specifically e-cigarettes) are needed to achieve maximal reductions in smoking.
Interventions
- OTHER Normal Nicotine Content Vape with all flavor e-liquids
- OTHER Normal nicotine content vape with tobacco e-liquids
- OTHER Low nicotine content vape with all flavor e-liquids
- OTHER Low nicotine content vape with tobacco e-liquids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2022-07-27 |
| Est. Completion | 2023-08-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05320887
The ClinicalTrials.gov registry entry for NCT05320887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Normal Nicotine Content Vape with all flavor e-liquids is the first listed.
NCT05320887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05320887 about?
NCT05320887 is a clinical study titled "Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM)". This study is proposing a four condition Electronic Tobacco Marketplace (ETM) study to determine if banning normal nicotine content (NNC) is sufficient for encouraging smokers to switch to potentially less harmful products or if the availability of higher nicotine and/or flavored alternative product...
What is the current status of trial NCT05320887?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2022-07-27. Estimated completion is 2023-08-06.
What interventions are being tested in trial NCT05320887?
The interventions under investigation include: Normal Nicotine Content Vape with all flavor e-liquids (OTHER), Normal nicotine content vape with tobacco e-liquids (OTHER), Low nicotine content vape with all flavor e-liquids (OTHER), Low nicotine content vape with tobacco e-liquids (OTHER).
Who is sponsoring clinical trial NCT05320887?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.